Telesis Bio partners with Danaher company Beckman Coulter
baona/iStock via Getty Images Financial terms of the deal were not disclosed. More on Danaher,
baona/iStock via Getty Images Financial terms of the deal were not disclosed. More on Danaher,
Summary: I reiterate my ‘Strong Buy’ rating for Danaher, with a one-year price target of
Danaher (NYSE:DHR) declares $0.27/share quarterly dividend, in line with previous. Forward yield 0.39% Payable Oct.
cagkansayin/iStock via Getty Images Update 4:55pm: Adds Fortive confirmation. Fortive Corp. (NYSE:FTV) rose 4% in
Summary: Danaher’s high valuation and flat 2024 EPS growth might raise eyebrows, but its track
mohd izzuan/iStock via Getty Images Danaher Corporation (NYSE:DHR) traded higher premarket Tuesday after the Washington,
Zerbor/iStock via Getty Images Danaher press release (NYSE:DHR): Q2 Non-GAAP EPS of $1.72 beats by
Danaher (NYSE:DHR) is scheduled to announce Q2 earnings results on Tuesday, July 23rd, before market
Summary: Danaher Corporation stock saw a high single-digit percentage increase from April to mid-June, but
Summary: The valuation is historically high, while sales are falling year-on-year. Danaher is issuing worse